Managing Pain Drugs Requires a Delicate Balance
Pain management drugs in phase 3 development show promise as abuse-deterrent formulations of opioid therapies.
SUBSCRIBE: Print / Digital / eNewsletter
Pain management drugs in phase 3 development show promise as abuse-deterrent formulations of opioid therapies.
How health systems are working to improve patient outcomes living with the virus.
Given the significant growth in genomics as a critical component of today’s medical/pharmacy care, genomics and genetic counselors are becoming increasingly important to healthcare executives.
Half of U.S. adults surveyed say they avoid seeking medical care because of cost, and they want upfront pricing of medical services.
The strongest associations were found for broad-spectrum antibiotics and those that act against anaerobic bacteria and fungi, study suggests.
A new survey reveals how patients are struggling to navigating the complex healthcare system and what concerns they have about it.
Patients may miss out on savings and making informed treatment decisions.
Preventive care is key to overcome the treatment and management challenges of this chronic condition.
New report examines opioid-related malpractice claims to identify risk factors, warning signs, and vulnerabilities in pain management.
Cancer care enters a new, exciting phase, experts say.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.